891P - Sexual satisfaction, anxiety, depression and quality of life amoung Turkish gynecological cancer patients

Date 08 October 2016
Event ESMO 2016 Congress
Session Poster Display
Topics Gynaecological Malignancies
Presenter Yasar Yildiz
Citation Annals of Oncology (2016) 27 (6): 296-312. 10.1093/annonc/mdw374
Authors Y. Yildiz1, M. Akyol2, A. Alacacioglu2, Y. Kucukzeybek2, N. Asık2, H. Taskaynatan3, U. Varol3, I. Yildiz4, U. Oflazoglu5, T. Salman3, S.U. Ozaltas2, M.O. Tarhan6
  • 1Katip Celebi University, Ataturk Training and Research Hospital,Izmir Katip Celebi University, 35360 - Izmir/TR
  • 2Medical Oncology, Ataturk Training and Research Hospital,Izmir Katip Celebi University, 35360 - Izmir/TR
  • 3Medical Oncology, Ataturk Training and Research Hospital,Izmir Katip Celebi University, 35965 - Izmir/TR
  • 4Oncology, Ataturk Training and Research Hospital,Izmir Katip Celebi University, Izmir/TR
  • 5Medical Oncology, Ataturk Egitim ve Arastirma Hastanesi tibbi onkoloji klinik, Izmir/TR
  • 6Medical Oncology, Dokuz Eylul University School of Medicine, Institute of Oncology, 35020 - Izmir/TR



Treatments of gynecologic cancer can impact a patient's self-esteem and body image and can create significant physical barriers, such as pain, to satisfactory sexual experiences, as treatments affect the organs associated with sexuality and in the period of life in which sexuality is of great importance. Gynecological cancer patients (GCPs) suffer from several physical and psychological problems. We aimed to investigate anxiety, depression, quality of life and sexual satisfaction levels of gynecological cancer patients (GCPs).


In this study, 62 patients with gynecologic cancer were included. The forms consist of Golombok- Rust Inventory of Ssexual Satisfaction (GRISS), State-Trait Anxiety (STAI) and European Organization for Research on Treatment of Cancer Questionnaires Quality of Life-C30 were used.


The EORTC-QLQ-C30 scores of the patients were compared with their anxiety, depression and hopelessness. There was a statistical significance in the physical functioning (p = 0.020), role functioning(p = 0.006) and emotional functioning (p= 0.0001) when the anxiety scores were high. There was a similar significance in the physical (p = 0.014), cognitive (p = 0.001) and social functions (p= 0.001) when the depression scores were high. When hopelessness scores were high, only physical functioning (p = 0.013) was notable. When we evaluated GRISS subscores and anxiety levels, we found significant increase in satisfaction (p = 0.03) and vaginismus (p = 0.002) in the GCPs. When we evaluated GRISS subscores and depression levels, GRISS subscores of the GCPs who had high depression scores were also high. However, statistical significance was found in satisfaction (p = 0.027), and erectile dysfunction (p = 0.043) subscores in the GCPs. There was a significance in the frequency (p= 0.017), satisfaction (p= 0.019) and avoidance (p = 0.032) in the high hopelessness score.


This study shows that there is a significant association with anxiety, depression symptoms and quality of life scores and sexual dysfunction. Patients' quality of life may be increased by taking precautions to reduce their psychosocial and psychosexual concerns.

Clinical trial identification

Legal entity responsible for the study

Ahmet Alacacıoglu


ızog (Izmir Oncology Group )


All authors have declared no conflicts of interest.